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SUMMARY
The onset, progression, and severity of epilepsy
vary between family members with identical
mutations in primary disease genes. The back-
ground of genetic variation unique to each individ-
ual genome contributes to clinical variation.
Known examples of gene interactions in human
families and mouse models provide insight into
underlying molecular mechanisms. For an
expanded treatment of this topic see Jasper’s Basic
Mechanisms of the Epilepsies, Fourth Edition
(Noebels JL, Avoli M, Rogawski MA, Olsen RW,
Delgado-Escueta AV, eds) published by Oxford
University Press. (available on the National
Library of Medicine Bookshelf [NCBI] at www.
ncbi.nlm.nih.gov/books).
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During the last decade, the genetic basis for many sei-
zure disorders has been identified by positional cloning of
Mendelian genes segregating in large pedigrees, and by
sequencing of candidate genes in sporadic cases and small
families. More than 700 different mutations in the sodium
channel gene SCN1A have been identified by these meth-
ods (Claes et al., 2009). It is now clear that different muta-
tions in the same gene can produce disorders that were
previously considered to be different entities (Meisler &
Kearney, 2005). Null mutations in SCN1A result in the
severe sporadic disorder Dravet’s syndrome, whereas mis-
sense mutations in the same gene produce the mild inher-
ited syndrome known as generalized epilepsy with febrile
seizures plus (GEFS+). However, even in individuals car-
rying the same sodium channel mutation, the clinical
course can vary dramatically (Catterall et al., 2008).
Genetic analysis in mouse models has revealed that strain
background can influence the phenotypic expression of a
disease mutation through the combined effects of many
genetic differences between the parental strains. If the
effects of modifier genes are sufficiently large, they may
be identified by positional cloning in crosses between
inbred strains. Another approach to identify genetic modi-
fiers is to test directly for gene interactions by breeding
mice that carry two epileptogenic mutations. Several
examples of genetic interactions between mutations in dif-
ferent ion channel genes have been described. The recent
advent of individual human genome sequencing has dem-
onstrated that we each carry hundreds of very rare coding
variants that change the amino acid sequences of cellular
proteins. As genome sequences become part of medical
records, information regarding genetic interactions and
modifier genes will be applied to develop better diagnosis,
prognosis, and treatment for patients with seizure
disorders.
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